Viatris
Viatris Inc. is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn. The company is dedicated to empowering people worldwide to live healthier at every stage of life by providing access to a broad and diverse portfolio of medicines. Its offerings span generics, complex generics, established brands, and innovative medicines across more than 10 major therapeutic areas, including cardiovascular, oncology, and infectious diseases.
The company operates at a massive scale, supplying medicines to approximately 1 billion patients annually across more than 165 countries and territories. Viatris leverages its extensive manufacturing network and scientific expertise to ensure a resilient supply of therapies, particularly in low- and middle-income countries. It focuses on both noncommunicable diseases (NCDs) and infectious diseases like HIV/AIDS and tuberculosis.
Viatris distinguishes itself through its "Partner of Choice" strategy, collaborating with global health organizations, governments, and medical associations to improve healthcare delivery and patient outcomes. The company invests in a deep R&D pipeline, focusing on complex products, new chemical entities, and life-cycle management to address significant unmet medical needs.
Headquartered in the United States, Viatris maintains major global centers in Pittsburgh, Pennsylvania; Shanghai, China; and Hyderabad, India. The company is listed on the NASDAQ Global Select Market under the ticker symbol VTRS.
- Founded
- 2020
- Company size
- 10001+ employees
- Type
- Public company
- Website: viatris.com
Industries: Pharmaceuticals, Healthcare
Categories: Drug Discovery
AntSpace put this profile together from public information. It may be incomplete; once Viatris claims it, its admins can edit everything here.
Our vision
Viatris aims to be a Partner of Choice to address areas of significant unmet patient need and to bridge the traditional divide between generics and brands.
Our culture
Viatris describes its culture as a "Culture that Cares," rooted in a people-first mindset where colleagues feel connected, supported, and empowered to make an impact. The company emphasizes acting decisively with ingenuity and resolve to meet patient needs. It fosters an environment that brings together diverse perspectives and embraces new ideas to solve meaningful healthcare challenges.
Core values
- Access
- Leadership
- Partnership
Specialties
- Cardiovascular Health
- Dermatology
- Diabetes and Metabolism
- Gastroenterology
- Respiratory and Allergy
- Women's Healthcare
Markets served
- Healthcare
- Generics
- Innovative Medicines
Key facts
- Legal name
- Viatris Inc.
- Employees
- 300,000
- Countries
- 165
- Stock listing
- NASDAQ: VTRS
- Public since
- 2020
Latest from Viatris
- Viatris Completes Acquisition of Pacira BioSciences (Company update · November 17, 2026)
The deal adds established treatments for acute postsurgical pain and osteoarthritis knee pain to the company's innovative medicines portfolio. - Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia (Product launch · October 16, 2026)
The U.S. Food and Drug Administration approved RYZUMVI, a phentolamine ophthalmic solution, for treating presbyopia in adults. - Viatris Announces Approval of WAKIX® (Pitolisant) in Japan (Product launch · September 16, 2026)
Japan's Ministry of Health, Labour and Welfare approved WAKIX for treating narcolepsy and excessive daytime sleepiness related to obstructive sleep apnea syndrome. It is the first histamine H3…
Products by Viatris
- ZILRETTA (triamcinolone acetonide extended-release injectable suspension) (Pharmaceutical / drug)
Non-opioid extended-release therapy for osteoarthritis knee pain.
Services by Viatris
- NCD Academy (Training & workshops · From 0 USD)
A free online education platform providing healthcare professionals with expert-led training on noncommunicable diseases.
Clients and partners
4 clients and partners
Case studies
1 case study
Upcoming events
- Evercore 9th Annual Healthcare Conference (Conference · December 1, 2026 · Online)
Documents
2 documents
2 more products, services and AI on AntSpace. Sign up free to see the full catalog.
Leadership, clients, case studies, documents and every location on AntSpace. Sign up free to see them.